NCT05984420 Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis Status RECRUITING Phase NA
NCT05971355 Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis Status RECRUITING Phase NA
NCT05970432 A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis Status UNKNOWN Phase PHASE2
NCT05969730 Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase NA
NCT05969717 Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic Dermatitis Status UNKNOWN Phase EARLY_PHASE1
NCT05958407 A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy Status COMPLETED Phase PHASE3
NCT05952986 A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults Status UNKNOWN Phase PHASE1
NCT05945810 Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT05938478 Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT Status RECRUITING Phase N/A
NCT05932888 Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT05932654 POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05928169 Determinants of Chronic Inflammatory Skin Disease Trajectories Status RECRUITING Phase N/A
NCT05923099 A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT05916365 Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT05911841 A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT05905133 A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05899816 A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) Status COMPLETED Phase PHASE3
NCT05891119 Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase EARLY_PHASE1